Richard Kibbey
Associate Director, Yale Program for Translational Biomedicine · Yale Program for Translational Biomedicine
Credentials: · · · · ·
History
- Present
Islet Cell Biology · Yale MMPC Phenotyping Core
PresentCore in Chemical Metabolism · Yale-New Haven Hospital
- Present
Endocrinology · Yale-New Haven Hospital
- 1998–2002
- 1987–1991
Trinity University
Research
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Nature · 2014 · 1,020 citations
Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome
Nature · 2016 · 1,009 citations
A roadmap for interpreting (13)C metabolite labeling patterns from cells
Review · Current Opinion in Biotechnology · 2015 · 516 citations
23 papers
- KP
6 papers
- SS
4 papers
- VS
4 papers
3 papers
- MS
3 papers
2 papers
2 papers
Grants
- 2023–2027
Posttranslational Neoantigens in Autoimmunity and Metabolism in T1D
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $2.9M · Yale University
- 2021–2027
Mitochondrial ADP Privation: A Unifying Model for Glucose-Induced Insulin Secretion.
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $3.4M · Yale University
- 2022–2023
Development of an Integrated Intermediary Metabolomics and Metabolic Flux Core
NIH Office of the Director · S10
Contact PI · $366.3K · Yale University
- 2016–2021
Comprehensive, Cross Platform-Validated 13C Flux Measures of Intra-and Inter-Tissue Metabolism
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $2.1M · Yale University